A detailed history of Prospector Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prospector Partners LLC holds 81,755 shares of PFE stock, worth $2.29 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
81,755
Previous 81,755 -0.0%
Holding current value
$2.29 Million
Previous $2.27 Million 0.84%
% of portfolio
0.27%
Previous 0.26%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $8.5 Million - $11 Million
-325,460 Reduced 79.92%
81,755 $2.35 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $3.86 Million - $4.52 Million
120,410 Added 41.98%
407,215 $13.5 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $396,417 - $458,645
10,975 Added 3.98%
286,805 $10.5 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $2.83 Million - $3.68 Million
71,730 Added 35.14%
275,830 $11.3 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $2.46 Million - $3.22 Million
59,025 Added 40.69%
204,100 $10.5 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $36,102 - $44,071
825 Added 0.57%
145,075 $6.35 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $90,733 - $107,581
1,950 Added 1.37%
144,250 $7.56 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $866,962 - $1.07 Million
-18,950 Reduced 11.75%
142,300 $7.37 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $2.26 Million - $3.35 Million
54,650 Added 51.27%
161,250 $9.52 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $4.18 Million - $5.37 Million
106,600 New
106,600 $4.59 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Prospector Partners LLC Portfolio

Follow Prospector Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.